Pfizer News

Drugmakers led by Pfizer Inc. would have to provide $156 billion in discounts over the next decade for medicines sold to low-income senior citizens under President Barack Obama's proposed fiscal 2013 budget.

Dr. David Meeker, president and CEO of Cambridge, Mass.-based biotechnology company Genzyme Corp., a Sanofi company; Dr.

BUYINS.NET: Market Maker Surveillance Report. PFE, GE, T, NUAN, CSCO, MSFT, Bearishly Biased Price Friction For Friday, February 10th 2012 BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday.

The following five companies all yield big dividends. To continue paying dividends at high rates, companies need to have growing or stable earnings that equate to positive cash flows.

More than half of lung and colon cancer patients may benefit from high-speed tests that detect DNA flaws doctors can target with existing medicines, a study found.

Andre Thieme began his 2012 Winter Circuit at HITS Ocala on Thursday with a lot to defend.

When Pfizer recalled a million packets of birth control pills, it set off two different forms of speculation about the possible consequences - whether a woman would get pregnant as a result of a packaging errors and whether Pfizer could be held responsible if an unintended pregnancy occurred.

For consumers who can't afford to pay for medications, the struggle can be literally a matter of life or death.

Johnson & Johnson , Pfizer Inc. A ,A Amgen, Inc. A : The FDA released guidelines for the first shortcut to the U.S. market for "biosimilar" drugs, less expensive versions of expensive and complex medicines made from biological matter.

BUYINS.NET: Market Maker Surveillance Report. CMCSA, PFE, BAC, NVDA, MSFT, TLEO, Bullishly Biased Price Friction For Thursday, February 9th 2012 BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday.

ANGEL FIRE, N.M., June 26, 2008 -- The Wall Street Bull Market Express is leaving the station and you have two months, maybe three to run down the platform, take the leap, and latch on to the caboose.

Seattle Genetics, Inc. A will unveil its latest earnings on Monday, February 13, 2012.A The average estimate of analysts is for a loss of 30 cents per share, a narrower loss from the year earlier quarter net loss of 34 cents.

GlaxoSmithKline Plc and Takeda Pharmaceutical Co. Ltd. said they are unlikely to build in-house diagnostic divisions like Roche Holding AG, which is bidding to take over a U.S. maker of gene-mapping tools.

Birth control pills are known to be nearly 100 percent effective when taken properly, but a recall of the drugs could send a shudder through women of childbearing age.

The Fed's promise of low interest rates is exciting news to both investors and companies.

Health-insurer WellPoint Inc. is planning to stop covering Pfizer Inc.'s Lipitor cholesterol-lowering pills for millions of members in favor of generic versions, marking a new challenge to Pfizer's efforts to fend off generic competition to its best-selling drug.

In a case concerning sanctions for willful violations of court-ordered discovery, the Eighth Circuit Court of Appeals held that the District Court for the Southern District of Iowa did not err in dismissing the Plaintiff's case under Federal Rule of Civil Procedure 37 and ordering that the Plaintiff pay the Defendant $53,255.55 in fees and costs ... (more)

If you're looking for a stock that could double over the next 12 months, your best bet is biotechnology.

More than 16 leading experts will provide insights on how to use and implement the new strategies in drug and medical device litigation.

Recent earnings reports from a few bellwethers in the pharmaceutical space suggest that more pain is likely ahead for the beleaguered industry.